125 related articles for article (PubMed ID: 37619661)
1. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
[TBL] [Abstract][Full Text] [Related]
2. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M
J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958
[TBL] [Abstract][Full Text] [Related]
5. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
[TBL] [Abstract][Full Text] [Related]
6. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
Chan J; Brown E; Dennis K; Milosevic M; Brundage M
Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
[TBL] [Abstract][Full Text] [Related]
7. Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales.
Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Barton MB
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):650-660. PubMed ID: 33750600
[TBL] [Abstract][Full Text] [Related]
8. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
Barton MB; Delaney GP
J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy utilization in developing countries: An IAEA study.
Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A
Radiother Oncol; 2018 Sep; 128(3):400-405. PubMed ID: 29859755
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites.
García Cabezas S; Palacios Eito A; Martínez Paredes M; Rivin del Campo E
Clin Transl Oncol; 2011 Feb; 13(2):115-20. PubMed ID: 21324800
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
[TBL] [Abstract][Full Text] [Related]
12. Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy.
Brada M; Ball C; Mitchell S; Forbes H; Ashley S
Radiother Oncol; 2019 Mar; 132():204-210. PubMed ID: 30392781
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit.
Gibberd A; Supramaniam R; Dillon A; Armstrong BK; O'Connell DL
BMC Cancer; 2016 Apr; 16():289. PubMed ID: 27112140
[TBL] [Abstract][Full Text] [Related]
14. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
15. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
Butler SM
J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
[TBL] [Abstract][Full Text] [Related]
16. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
[TBL] [Abstract][Full Text] [Related]
18. Utilisation of radiotherapy in lung cancer: A scoping narrative literature review with a focus on the introduction of evidence-based therapeutic approaches in Europe.
Corral J; Borras JM; Lievens Y
Clin Transl Radiat Oncol; 2024 Mar; 45():100717. PubMed ID: 38226026
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
[TBL] [Abstract][Full Text] [Related]
20. The effect of travel distance on radiotherapy utilization in NSW and ACT.
Gabriel G; Barton M; Delaney GP
Radiother Oncol; 2015 Nov; 117(2):386-9. PubMed ID: 26243679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
